Proteomics

Dataset Information

0

Ovarian cancer cell line landscape


ABSTRACT: Nine ovarian cancer cell lines were analyzed using phosphoproteomics and proteomics. The KURAMOCHI cell line was further subjected to treatment with the drug C26A6 and transfection with siRNA towards MTDH and SND1.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Malignant Neoplasm Of Ovary

SUBMITTER: Fredrik Levander  

LAB HEAD: Fredrik Levander

PROVIDER: PXD059892 | Pride | 2025-10-29

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
220516_EV1109_LW_A2780_S19.raw Raw
220516_EV1109_LW_A2780_S20.raw Raw
220516_EV1109_LW_A2780_S21.raw Raw
220516_EV1109_LW_A2780_S22.raw Raw
220516_EV1109_LW_A2780_S23.raw Raw
Items per page:
1 - 5 of 165
altmetric image

Publications

Proteomics discovery of MTDH and SND1 interaction vulnerabilities in ovarian cancer.

Esmaeili Parisa P   Nasimian Ahmad A   Werner Lucas L   Junior Sergio Mosquim SM   Jakobsson Magnus E ME   Gerdtsson Anna Sandström AS   Kazi Julhash U JU   Levander Fredrik F  

Scientific reports 20251124 1


High-grade serous ovarian cancer (HGSOC) is the most prevalent and aggressive subtype of ovarian cancer. The combination of late-stage diagnosis and the tendency to exhibit resistance to existing treatments highlights a critical gap in effective therapeutic options. There is thus a need for novel strategies for targeting HGSOC, particularly in its advanced stages. To address this gap, we developed a comprehensive atlas profiling both the proteome and phosphoproteome levels across a panel of nine  ...[more]

Similar Datasets

2025-11-18 | PXD068388 | Pride
2024-08-28 | PXD047828 | Pride
2025-11-18 | PXD068392 | Pride
2011-12-31 | E-MTAB-808 | biostudies-arrayexpress
2022-05-25 | E-MTAB-11650 | biostudies-arrayexpress
2025-05-06 | PXD045469 | Pride
2024-09-12 | PXD045466 | Pride
2012-05-23 | E-GEOD-32894 | biostudies-arrayexpress
2019-12-12 | PXD013453 | Pride
2025-05-07 | PXD062327 | Pride